PubMed for id: 7364

Year	Number of Results
1990	1
1994	2
1995	1
1999	2
2000	4
2002	3
2003	6
2004	10
2005	6
2006	8
2007	18
2008	16
2009	18
2010	23
2011	9
2012	13
2013	13
2014	4
2015	13
2016	5
2017	10
2018	12
2019	7
2020	8
2021	4
2022	3
2023	2
2024	0

1

The N⁶-methyladenosine modification posttranscriptionally regulates hepatic UGT2B7 expression.

Ondo K, Isono M, Nakano M, Hashiba S, Fukami T, Nakajima M. Ondo K, et al. Biochem Pharmacol. 2021 Jul;189:114402. doi: 10.1016/j.bcp.2020.114402. Epub 2020 Dec 30. Biochem Pharmacol. 2021. PMID: 33387482

2

Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity.

Nair PC, Chau N, McKinnon RA, Miners JO. Nair PC, et al. Mol Pharmacol. 2020 Dec;98(6):710-718. doi: 10.1124/molpharm.120.000104. Epub 2020 Oct 2. Mol Pharmacol. 2020. PMID: 33008919

3

Influences of UGT2B7 rs7439366 and rs12233719 Polymorphisms on Fentanyl Sensitivity in Chinese Gynecologic Patients.

Yang Z, Yin Q, Li X. Yang Z, et al. Med Sci Monit. 2020 May 13;26:e924153. doi: 10.12659/MSM.924153. Med Sci Monit. 2020. PMID: 32401749 Free PMC article.

4

The Human UGT2B7 Nanodisc.

Cook I, Asenjo AB, Sosa H, Leyh TS. Cook I, et al. Drug Metab Dispos. 2020 Mar;48(3):198-204. doi: 10.1124/dmd.119.089946. Epub 2019 Dec 31. Drug Metab Dispos. 2020. PMID: 31892527 Free PMC article.

5

Associations between UGT2B7 polymorphisms and cancer susceptibility: A meta-analysis.

Shen ML, Xiao A, Yin SJ, Wang P, Lin XQ, Yu CB, He GH. Shen ML, et al. Gene. 2019 Jul 20;706:115-123. doi: 10.1016/j.gene.2019.05.025. Epub 2019 May 10. Gene. 2019. PMID: 31082503 Review.

6

Investigation of the Endoplasmic Reticulum Localization of UDP-Glucuronosyltransferase 2B7 with Systematic Deletion Mutants.

Miyauchi Y, Kimura S, Kimura A, Kurohara K, Hirota Y, Fujimoto K, Mackenzie PI, Tanaka Y, Ishii Y. Miyauchi Y, et al. Mol Pharmacol. 2019 May;95(5):551-562. doi: 10.1124/mol.118.113902. Epub 2019 Apr 3. Mol Pharmacol. 2019. PMID: 30944207

7

Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population.

Glatard A, Guidi M, Dobrinas M, Cornuz J, Csajka C, Eap CB. Glatard A, et al. Eur J Clin Pharmacol. 2019 Jul;75(7):939-949. doi: 10.1007/s00228-019-02662-9. Epub 2019 Mar 13. Eur J Clin Pharmacol. 2019. PMID: 30868192 Clinical Trial.

8

Correlation of UGT2B7 Polymorphism with Cardiotoxicity in Breast Cancer Patients Undergoing Epirubicin/Cyclophosphamide-Docetaxel Adjuvant Chemotherapy.

Li H, Hu B, Guo Z, Jiang X, Su X, Zhang X. Li H, et al. Yonsei Med J. 2019 Jan;60(1):30-37. doi: 10.3349/ymj.2019.60.1.30. Yonsei Med J. 2019. PMID: 30554488 Free PMC article.

9

Relationship Between UGT1A4 and UGT2B7 Polymorphisms and the Steady-State Plasma Concentrations of Lamotrigine in Patients With Treatment-Resistant Depressive Disorder Receiving Lamotrigine as Augmentation Therapy.

Suzuki T, Mihara K, Nagai G, Kagawa S, Nakamura A, Nemoto K, Kondo T. Suzuki T, et al. Ther Drug Monit. 2019 Feb;41(1):86-90. doi: 10.1097/FTD.0000000000000577. Ther Drug Monit. 2019. PMID: 30489548

10

Association between UDP-glucuronosyltransferase 2B7 tagSNPs and breast cancer risk in Chinese females.

He BX, Qiao B, Lam AK, Zhao XL, Zhang WZ, Liu H. He BX, et al. Clin Exp Pharmacol Physiol. 2018 May;45(5):437-443. doi: 10.1111/1440-1681.12908. Epub 2018 Feb 7. Clin Exp Pharmacol Physiol. 2018. PMID: 29272031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

193 results

Results by year